Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 110
  • Start Date: September 1, 2022
The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease, a Double Blind Placebo Controlled Randomized Clinical Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 70
  • Start Date: March 31, 2021
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter, 16-Week, Phase 3 Study to Investigate the Efficacy and Safety of Secukinumab (AIN457) 300 mg s.c. in Adult Patients With Active, Moderate to Severe Thyroid Eye Disease
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 54
  • Start Date: January 1, 2021
A Phase II, Randomized, Cross-over, Placebo-controlled, Double-blind, Single-center, Clinical Trial to Evaluate the Efficacy of Sirolimus in Patients With Graves' Disease and Moderate-to-severe and Active Graves' Orbitopathy (GO)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug, Radiation
  • Participants: 120
  • Start Date: January 1, 2021
A Phase IV, Randomized, Multi-center Clinical Trial to Compare the Efficacy of Orbital Radiotherapy in Association With Intravenous Glucocorticoids vs Intravenous Glucocorticoids Alone for Moderately Severe and Active Graves' Orbitopathy
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 80
  • Start Date: December 22, 2020
Analysis of Bisphenol A Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: November 13, 2020
Randomized Controlled Trial of Preoperative Steroids in Autoimmune Thyroid Disease
Clinical Trial
  • Status: Recruiting
  • Participants: 15
  • Start Date: November 1, 2020
Immunological Follow-up of Patients With Basedow's Orbitopathy : SIPO
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 60
  • Start Date: November 2020
Total Versus Subtotal Thyroidectomy in Graves' Disease : A Randomized Controlled Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Radiation, Device
  • Participants: 156
  • Start Date: September 2020
A Randomized, Open-label, Parallel-group Study to Determine the Efficacy of Sequential High-intensity Focused Ultrasound (HIFU) Ablation Versus Fixed-dose Radioiodine-131 Therapy in Moderate-sized Non-toxic Multinodular Goiter
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: May 19, 2020
A Prospective Study Analyzing the Change of Gut Microbiome With Antithyroid Drug Treatment of Graves' Disease
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 4000
  • Start Date: March 2020
The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions in Alopecia Areata
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 270
  • Start Date: November 25, 2019
Randomized Clinical Trial, Blinded for the Researcher and Multicenter, to Evaluate the Efficacy and Safety of Preoperative Preparation With Lugol Solution in Euthyroid Patients With Graves-Basedow Disease.
Showing 1-12 of 37